Citation: C. Marth et al., 10-YEAR RESULTS OF A RANDOMIZED TRIAL COMPARING CISPLATIN WITH CISPLATIN AND CYCLOPHOSPHAMIDE IN ADVANCED, SUBOPTIMALLY DEBULKED OVARIAN-CANCER, European journal of cancer, 34(8), 1998, pp. 1175-1180
Authors:
HOFSTRA LS
KRISTENSEN GB
WILLEMSE PHB
VINDEVOGHEL A
MEDEN H
LAHOUSEN M
OBERLING F
SORBE B
CRUMP M
SKLENAR I
SLUITER WJ
KIESE B
TROPE CG
DEVRIES EGE
Citation: Ls. Hofstra et al., RANDOMIZED TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-3 VERSUS PLACEBO INPREVENTION OF BONE-MARROW DEPRESSION DURING FIRST-LINE CHEMOTHERAPY FOR OVARIAN-CARCINOMA, Journal of clinical oncology, 16(10), 1998, pp. 3335-3344
Authors:
SKOMEDAL H
KRISTENSEN GB
ABELER VM
BORRESENDALE AL
TROPE C
HOLM R
Citation: H. Skomedal et al., TP53 PROTEIN ACCUMULATION AND GENE MUTATION IN RELATION TO OVEREXPRESSION OF MDM2 PROTEIN IN OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS, Journal of pathology, 181(2), 1997, pp. 158-165
Authors:
HELLAND A
BORRESENDALE AL
PELTOMAKI P
HEKTOEN M
KRISTENSEN GB
NESLAND JM
DELACHAPELLE A
LOTHE RA
Citation: A. Helland et al., MICROSATELLITE INSTABILITY IN CERVICAL AND ENDOMETRIAL CARCINOMAS, International journal of cancer, 70(5), 1997, pp. 499-501
Authors:
KRISTENSEN GB
KARLSEN F
JENKINS A
KAERN J
ABELER VM
TROPE CG
Citation: Gb. Kristensen et al., HUMAN PAPILLOMA-VIRUS HAS NO PROGNOSTIC-SIGNIFICANCE IN CERVICAL-CARCINOMA, European journal of cancer, 32A(8), 1996, pp. 1349-1353
Citation: Rr. Nordal et al., THE PROGNOSTIC-SIGNIFICANCE OF SURGERY, TUMOR SIZE, MALIGNANCY GRADE,MENOPAUSAL STATUS, AND DNA-PLOIDY IN ENDOMETRIAL STROMAL SARCOMA, Gynecologic oncology, 62(2), 1996, pp. 254-259
Citation: Gb. Kristensen et al., EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF NM23 NDP KINASE PROTEIN EXPRESSION IN CERVICAL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY/, Gynecologic oncology, 61(3), 1996, pp. 378-383
Authors:
SCHEISTROEN M
TROPE C
KAERN J
ABELER VM
PETTERSEN EO
KRISTENSEN GB
Citation: M. Scheistroen et al., MALIGNANT-MELANOMA OF THE VULVA FIGO STAGE-I - EVALUATION OF PROGNOSTIC FACTORS IN 43 PATIENTS WITH EMPHASIS ON DNA-PLOIDY AND SURGICAL-TREATMENT, Gynecologic oncology, 61(2), 1996, pp. 253-258
Citation: J. Kaern et al., CISPLATIN 5-FLUOROURACIL TREATMENT OF RECURRENT CERVICAL-CARCINOMA - A PHASE-II STUDY WITH LONG-TERM FOLLOW-UP/, Gynecologic oncology, 60(3), 1996, pp. 387-392
Citation: Gb. Kristensen et al., EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND C-ERBB-2 IN EARLY CERVICAL SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY, Cancer, 78(3), 1996, pp. 433-440
Authors:
HAGMAR B
CHRISTENSEN JJP
JOHANSSON B
KALANTARI M
RYD W
SKYLDBERG B
WALAAS L
WARLEBY B
KRISTENSEN GB
Citation: B. Hagmar et al., IMPLICATIONS OF HUMAN PAPILLOMAVIRUS TYPE FOR SURVIVAL IN CERVICAL SQUAMOUS-CELL CARCINOMA, International journal of gynecological cancer, 5(5), 1995, pp. 341-345
Authors:
KRISTENSEN GB
BAEKELANDT M
VERGOTE IB
TROPE C
Citation: Gb. Kristensen et al., A PHASE-II STUDY OF CARBOPLATIN AND HEXAMETHYLMELAMINE AS INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA (AOC), European journal of cancer, 31A, 1995, pp. 505-505
Citation: Gb. Kristensen et al., THE PROGNOSTIC-SIGNIFICANCE OF NM23, CATHEPSIN-D, EGFR AND C-ERBB-2 IN CERVICAL-CANCER, European journal of cancer, 31A, 1995, pp. 1184-1184
Authors:
KRISTENSEN GB
BAEKELANDT M
VERGOTE IB
TROPE C
Citation: Gb. Kristensen et al., A PHASE-II STUDY OF CARBOPLATIN AND HEXAMETHYLMELAMINE AS INDUCTION CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA, European journal of cancer, 31A(11), 1995, pp. 1778-1780
Citation: Rr. Nordal et al., THE PROGNOSTIC-SIGNIFICANCE OF STAGE, TUMOR SIZE, CELLULAR ATYPIA ANDDNA-PLOIDY IN UTERINE LEIOMYOSARCOMA, Acta oncologica, 34(6), 1995, pp. 797-802
Authors:
KRISTENSEN GB
KAERN J
ABELER VM
HAGMAR B
TROPE CG
PETTERSEN EO
Citation: Gb. Kristensen et al., NO PROGNOSTIC IMPACT OF FLOW-CYTOMETRIC MEASURED DNA-PLOIDY AND S-PHASE FRACTION IN CANCER OF THE UTERINE CERVIX - A PROSPECTIVE-STUDY OF 465 PATIENTS, Gynecologic oncology, 57(1), 1995, pp. 79-85
Authors:
MAKAR AP
BAEKELANDT M
TROPE CG
KRISTENSEN GB
Citation: Ap. Makar et al., THE PROGNOSTIC-SIGNIFICANCE OF RESIDUAL DISEASE, FIGO SUBSTAGE, TUMORHISTOLOGY, AND GRADE IN PATIENTS WITH FIGO STAGE-III OVARIAN-CANCER, Gynecologic oncology, 56(2), 1995, pp. 175-180
Authors:
SCHEISTROEN M
TROPE C
KOERN J
PETTERSEN EO
ABELER VM
KRISTENSEN GB
Citation: M. Scheistroen et al., MALIGNANT-MELANOMA OF THE VULVA - EVALUATION OF PROGNOSTIC FACTORS WITH EMPHASIS ON DNA-PLOIDY IN 75 PATIENTS, Cancer, 75(1), 1995, pp. 72-80
Authors:
MAKAR AP
HOLM R
KRISTENSEN GB
NESLAND JM
TROPE CG
Citation: Ap. Makar et al., THE EXPRESSION OF C-ERBB-2 (HER-2 NEU) ONCOGENE IN INVASIVE OVARIAN MALIGNANCIES/, International journal of gynecological cancer, 4(3), 1994, pp. 194-199
Citation: A. Dorum et al., RANDOMIZED STUDY OF CISPLATIN VERSUS THIOTEPA AS INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA, European journal of cancer, 30A(10), 1994, pp. 1470-1474